LipoTrue Debuts Glintarine, Red Aternaliss, Kalizyme Actives

LipoTrue has introduced three new biotechnological actives — Glintarine, Red Aternaliss and Kalizyme — according to a Cosmetics Business report that first carried the announcement. The report names all three actives at once but does not detail pricing, formulation chemistry or target skin applications for any of them individually.

What Did LipoTrue Announce?

LipoTrue announced three new biotechnological actives simultaneously: Glintarine, Red Aternaliss and Kalizyme, per Cosmetics Business. The publication's account is currently the only reporting available on the launch, and it functions largely as a notice naming the three ingredients rather than a full technical rundown.

What Are Glintarine, Red Aternaliss and Kalizyme?

Based on the available report, Glintarine, Red Aternaliss and Kalizyme are proprietary names LipoTrue has assigned to its newest active ingredients. The report does not specify the production method behind any of the three, whether that is fermentation, cell culture, enzymatic synthesis or another biotechnological process, nor does it state which skin concerns — pigmentation, barrier function, firmness or otherwise — each active is formulated to address.

No pricing, regulatory status or target skin concern has been disclosed for any of the three actives in the available reporting.

What Does "Biotechnological Active" Mean in Cosmetics?

In cosmetic formulation, the term broadly describes ingredients produced through biological processes rather than conventional chemical synthesis or direct plant extraction. Suppliers often use the label to signal a controlled, lab-based production method. The specific process behind Glintarine, Red Aternaliss or Kalizyme has not been disclosed in the current report, so the term should be read here as a category label rather than a technical specification.

What Details Has LipoTrue Released So Far?

The Cosmetics Business account reads as a launch notice: three new names tied to one supplier. Brand chemists and formulators who typically evaluate new actives through technical dossiers, INCI listings and published efficacy studies will need LipoTrue's own technical materials, or fuller trade coverage, before those ingredients can be assessed for formulation use.

Why Does a New Active-Ingredient Launch Matter to the Market?

Ingredient suppliers routinely introduce named actives to differentiate their catalogs for brand customers, who in turn use those names as marketing claims on finished-product labels. Whether Glintarine, Red Aternaliss or Kalizyme becomes a recognizable label claim will depend on uptake among formulators and on data LipoTrue has not yet made public in the current reporting.

Where Can Readers Track Additional Coverage?

Readers following ingredient science can check the original Cosmetics Business report for updates as LipoTrue discloses more technical information. For broader context on how newer actives typically get evaluated against established ingredients, see HTT's related coverage on science-backed skin care routine tips and on retinol versus retinal differences.